DYNO MCAP Trademark

Trademark Overview


On Friday, June 9, 2023, a trademark application was filed for DYNO MCAP with the United States Patent and Trademark Office. The USPTO has given the DYNO MCAP trademark a serial number of 98035251. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 19, 2024. This trademark is owned by Dyno Therapeutics, Inc.. The DYNO MCAP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations containing adeno-associated virus (AAV) protein sequences and nucleic acid sequences for use in gene delivery; Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; pharmaceutical preparations, namely, therapeutic pharmaceuticals in the nature of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for the treatment of gene therapy treatable diseases; Pharmaceutical preparations in the nature of genetically modified cells for use in the production of pharmaceutical preparations and products, for use in gene therapy for medical purposes; Drug delivery agents in the form of viral vectors comprised of non-natural and synthetic adeno-associated virus (AAV) protein sequen...
dyno mcap

General Information


Serial Number98035251
Word MarkDYNO MCAP
Filing DateFriday, June 9, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, November 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 8, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations containing adeno-associated virus (AAV) protein sequences and nucleic acid sequences for use in gene delivery; Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; pharmaceutical preparations, namely, therapeutic pharmaceuticals in the nature of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for the treatment of gene therapy treatable diseases; Pharmaceutical preparations in the nature of genetically modified cells for use in the production of pharmaceutical preparations and products, for use in gene therapy for medical purposes; Drug delivery agents in the form of viral vectors comprised of non-natural and synthetic adeno-associated virus (AAV) protein sequences and nucleic acid sequences for medical and pharmaceutical purposes; Pharmaceutical preparations for scientific research and pharmaceutical research for the treatment and prevention of gene therapy treatable diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDyno Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Party NameDyno Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events


Event DateEvent Description
Thursday, July 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 5, 2024ASSIGNED TO EXAMINER
Tuesday, February 13, 2024NON-FINAL ACTION WRITTEN
Tuesday, February 13, 2024NON-FINAL ACTION E-MAILED
Tuesday, February 13, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 5, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, April 5, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, June 13, 2023NEW APPLICATION ENTERED
Monday, July 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 30, 2024EXAMINERS AMENDMENT E-MAILED
Friday, August 30, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, August 30, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 30, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 9, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 18, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 8, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 8, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 19, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 30, 2024EXAMINER'S AMENDMENT ENTERED
Friday, December 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED